Improving Management of Post-partum Haemorrhage With Quantra® System

Use of Quantra® System in Clinical Practice to Improve Management of Post-partum Haemorrhage : a Prospective Study

Post partum haemorrhage is a concerning situation in maternity wards, though it is not the first cause of maternal mortality anymore.

It has been already shown that low fibrinogen level is a major predictive factor of massive bleeding after delivery.

In this situation, the early knowledge of fibrinogen level could enhance care of women experiencing post partum haemorrhage.

In a cohort of women suffering from post partum haemorrhage, this study will evaluate whether assessing fibrinogen level would be faster using the Quantra® system than the standard coagulation test.

Inclusion Criteria:

Women ≥ 18 years old Experiencing post partum haemorrhage ≥ 500 mL Within 24 hours after delivery

Exclusion Criteria:

• Previous anemia ≤ 7g/dL
• Known bleeding disorders
• Ongoing antiplatelets treatment
• Ongoing anticoagulant treatment